Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal

Rossella Elisei, M. Schlumberger, A. Driedger, C. Reiners, R. T. Kloos, S. I. Sherman, B. Haugen, C. Corone, E. Molinaro, L. Grasso, S. Leboulleux, I. Rachinsky, M. Luster, M. Lassmann, N. L. Busaidy, R. L. Wahl, F. Pacini, S. Y. Cho, J. Magner, A. PincheraP. W. Ladenson

Research output: Contribution to journal › Article › peer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry